This work is supported in part by SmartState Cancer Stem Cell Biology&Therapy Program and by R01 grants from the National Institutes of Health,including AI118305,HL140953 and CA258440(X.-Z.Y.).
Graft-versus-host disease (GVHD) significantly contributes to patient morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HSCT). Sphingosine-1-phosphate (S1P) signaling is involved in the...
supported by grants from the National Key Research and Development Program of China(2017YFA0104500);the Beijing Municipal Science and Technology Commission(Z181100009618032);the National Natural Science Foundation of China(Grant No.81621001,81530046,81770189,81670186,81870141 and 82070185);CAMS Innovation Fund for Medical Sciences(CIFMS)(grant number:2019-I2M-5-034);the Peking University Clinical Scientist Program(BMU2019LCKXJ003).
Haploidentical stem cell transplantation(haplo-SCT)achieves superior or at least comparable clinical outcomes to HLA-matched sibling donor transplantation(MSDT)in treating hematological malignancies.To define the unde...
the Department of Energy for funding the experimental part of this work under grant DE-SC0004600;the theoretical part under grant DE-EE0006287 of the Bioenergy Technology Office CHASE program
The present work explores the reaction pathways of γ-valerolactone(GVL) over a supported ruthenium catalyst. The conversion of GVL in aqueous phase over a 5% Ru/C catalyst was investigated in a batch reactor operatin...